ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 768

Inhibition Of X-Box Binding Protein 1 (XBP1) Is Chondroprotective By Promoting Autophagy and Inhibiting Catabolic Responses

Ru L. Bryan1, Robert Terkeltaub2 and Ramon Serrano3, 1Medicine-Rheumatology, VA Medical Center/University of California San Diego, San Diego, CA, 2Medicine-Rheumatology, VA Medical Ctr/University of California San Diego, San Diego, CA, 3VA Medical Center, San Diego, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cartilage and chondrocytes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint I: Cartilage Biology and Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Chondrocyte stress responses to biomechanical injury and joint inflammation, and associated changes in differentiation and function, provide a foundation upon which cartilage injury and OA can be triggered and accelerated. Fundamental proteostasis responses by which cells normally resolve stress include the unfolded protein response (UPR), which restores equilibrium to the stressed ER via a reprogrammed proteome, rich in chaperones and protein folding catalysts. The UPR also regulates oxidative stress responses, inflammation, and cell fate including autophagy. Chondrocyte autophagy is impaired in biomechanical cartilage explant injury, and in aging and OA cartilage. Autophagy repairs damaged cell organelles and is anti-inflammatory, in part by degrading pro-IL-1beta. The UPR can promote autophagy and autophagy promotes normal UPR and mitochondrial functional. UPR-specific XBP1 alternative mRNA splicing generates the potent transcriptional activator XBP1s, which can exert either promote or inhibit autophagy or inflammation depending on cell type and context. In this study, we tested the hypothesis that XBP1 activation is noxious in chondrocytes by impairing autophagy.

Methods:

We knocked down XBP1 expression in cultured normal human chondrocytes (passage 1) via siRNA transfection. After 48 hours, the XBP1 knockdown chondrocytes were subjected to SDS-PAGE/Western blot analysis for phosphorylation of the autophagy promoter AMPKα, expression of FOXO1, transglutaminase 2, and the autophagy proteins LC3, and p62.  XBP1 knockdown chondrocytes were also treated with IL-1β for 18 hours, and nitric oxide (NO) production and MMP-3 release were measured from the conditioned media by Griess reaction method and Western blot, respectively.

Results:

We observed markedly increased activation of XBP1 in human knee OA chondrocytes. In XBP1 knockdown human knee chondrocytes, we observed increased basal levels of expression of the autophagy promoter FOXO1, and increasing LC3 conversion from I to II, and decreased basal levels of expression of p62, indicating induction of autophagy. This was linked with increased basal level of phosphorylation of the autophagy promoter, anti-inflammatory mediator and metabolic super-regulator AMPK in the XBP1 knockdown chondrocytes. Conversely, IL-1β-induced release of NO and MMP-3 was significantly inhibited in the XBP1 knockdown chondrocytes. Last, basal expression of transglutaminase 2, which transduced inflammatory responses of IL-1β and chemokines in chondrocytes, was blunted in the XBP1 knockdown chondrocytes.

Conclusion:

This study demonstrated increased UPR-specific XBP1 activation in human knee OA cartilage, and that XBP1 critically transduces noxious functions in chondrocytes, including impairment of autophagy, and pro-catabolic activities, mediated by regulation of AMPK and transglutaminase activity. These findings identify XBP1 as a novel target to limit OA progression.


Disclosure:

R. L. Bryan,
None;

R. Terkeltaub,
None;

R. Serrano,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inhibition-of-x-box-binding-protein-1-xbp1-is-chondroprotective-by-promoting-autophagy-and-inhibiting-catabolic-responses/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology